Vascular endothelial dysfunction in cirrhosis

Journal of Hepatology

Volumn 46, Issue 5, 2007, Pages 927-934

  Iwakiri, Yasuko ^a,b   Groszmann, Roberto J ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBON MONOXIDE; NITRIC OXIDE; PROSTACYCLIN; VASCULOTROPIN; VASODILATOR AGENT;

CELL ACTIVITY; CELL FUNCTION; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LIVER CIRRHOSIS; NONHUMAN; OXIDATIVE STRESS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; REVIEW; SPLANCHNIC BLOOD FLOW; SYSTEMIC CIRCULATION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; MICROCIRCULATION; NITRIC OXIDE; REGIONAL BLOOD FLOW; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 34047175876     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.02.006     Document Type: Review

References (92)

1. Caballero A.E. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11 (2003) 1278-1289
2. Racanelli V., and Rehermann B. The liver as an immunological organ. Hepatology 43 (2006) S54-S62
3. Mano T., Masuyama T., Yamamoto K., Naito J., Kondo H., Nagano R., et al. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J 131 (1996) 231-238
4. Tooke J.E. Microvascular function in human diabetes. A physiological perspective. Diabetes 44 (1995) 721-726
5. Shah V., Wiest R., Garcia-Cardena G., Cadelina G., Groszmann R.J., and Sessa W.C. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am J Physiol 277 (1999) G463-G468
6. Tsai M.H., Iwakiri Y., Cadelina G., Sessa W.C., and Groszmann R.J. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology 125 (2003) 1452-1461
7. Wiest R., Shah V., Sessa W.C., and Groszmann R.J. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 276 (1999) G1043-G1051
8. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
9. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84 (1987) 9265-9269
10. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83 (1989) 1774-1777
11. Pearson P.J., Schaff H.V., and Vanhoutte P.M. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries. Circulation 81 (1990) 1921-1927
12. Muhl H., and Dinarello C.A. Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-l-arginine. J Immunol 159 (1997) 5063-5069
13. Frisbee J.C., and Stepp D.W. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 281 (2001) H1304-H1311
14. Battaglia S., Angus P., and Chin-Dusting J.P. Role of the endothelium on vasoactive agents in patients with liver cirrhosis. J Gastroenterol Hepatol 21 (2006) 1189-1193
15. Napoli R., Biondi B., Guardasole V., Matarazzo M., Pardo F., Angelini V., et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 104 (2001) 3076-3080
16. Iwakiri Y., and Groszmann R.J. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43 (2006) S121-S131
17. Groszmann R.J., and Abraldes J.G. Portal hypertension: from bedside to bench. J Clin Gastroenterol 39 (2005) S125-S130
18. Wiest R., and Groszmann R.J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 35 (2002) 478-491
19. Groszmann R.J., Loureiro-Silva M., and Tsai M.H. The biology of portal hypertension. 4 ed. (2001), Lippincott Williams and Wilkins, New York 679-97
20. McCuskey R.S., and Reilly F.D. Hepatic microvasculature: dynamic structure and its regulation. Semin Liver Dis 13 (1993) 1-12
21. Braet F., and Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 1 (2002) 1
22. Ueno T., Bioulac-Sage P., Balabaud C., and Rosenbaum J. Innervation of the sinusoidal wall: regulation of the sinusoidal diameter. Anat Rec A Discov Mol Cell Evol Biol 280 (2004) 868-873
23. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
24. Shah V., Haddad F.G., Garcia-Cardena G., Frangos J.A., Mennone A., Groszmann R.J., et al. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 100 (1997) 2923-2930
25. Kawada N., Tran-Thi T.A., Klein H., and Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213 (1993) 815-823
26. Liu S., Premont R.T., Kontos C.D., Huang J., and Rockey D.C. Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt. J Biol Chem 278 (2003) 49929-49935
27. Gupta T.K., Toruner M., Chung M.K., and Groszmann R.J. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28 (1998) 926-931
28. Bellis L., Berzigotti A., Abraldes J.G., Moitinho E., Garcia-Pagan J.C., Bosch J., et al. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis. Hepatology 37 (2003) 378-384
29. Bosch J., and Garcia-Pagan J.C. Complications of cirrhosis. I. Portal hypertension. J Hepatol 32 (2000) 141-156
30. Graupera M., Garcia-Pagan J.C., Abraldes J.G., Peralta C., Bragulat M., Corominola H., et al. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 37 (2003) 172-181
31. Dudenhoefer A.A., Loureiro-Silva M.R., Cadelina G.W., Gupta T., and Groszmann R.J. Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers. Hepatology 36 (2002) 381-385
32. Sakamoto M., Ueno T., Nakamura T., Sakata R., Hasimoto O., Torimura T., et al. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen. Eur J Clin Invest 35 (2005) 220-225
33. Zafra C., Abraldes J.G., Turnes J., Berzigotti A., Fernandez M., Garca-Pagan J.C., et al. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology 126 (2004) 749-755
34. Hernandez-Guerra M., Garcia-Pagan J.C., Turnes J., Bellot P., Deulofeu R., Abraldes J.G., et al. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. Hepatology 43 (2006) 485-491
35. Mori T., Okanoue T., Sawa Y., Hori N., Ohta M., and Kagawa K. Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology 17 (1993) 891-897
36. Ogawa H. Scanning electron microscopy of rat liver hyperplastic nodules induced by diethylnitrosamine. Scan Electron Microsc (1982) 1793-1798
37. Ishak K.G., Zimmerman H.J., and Ray M.B. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 15 (1991) 45-66
38. Martinez-Hernandez A., and Martinez J. The role of capillarization in hepatic failure: studies in carbon tetrachloride-induced cirrhosis. Hepatology 14 (1991) 864-874
39. Bhunchet E., and Fujieda K. Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: a mechanism to maintain liver blood flow. Hepatology 18 (1993) 1450-1458
40. Fraser R., Dobbs B.R., and Rogers G.W. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 21 (1995) 863-874
41. Rogers G.W., Dobbs B.R., and Fraser R. Decreased hepatic uptake of cholesterol and retinol in the dimethylnitrosamine rat model of cirrhosis. Liver 12 (1992) 326-329
42. Graupera M., March S., Engel P., Rodes J., Bosch J., and Garcia-Pagan J.C. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. Am J Physiol Gastrointest Liver Physiol 288 (2005) G763-G770
43. Yokoyama H., Fukuda M., Okamura Y., Mizukami T., Ohgo H., Kamegaya Y., et al. Superoxide anion release into the hepatic sinusoid after an acute ethanol challenge and its attenuation by Kupffer cell depletion. Alcohol Clin Exp Res 23 (1999) 71S-75S
44. Hasegawa T., Kikuyama M., Sakurai K., Kambayashi Y., Adachi M., Saniabadi A.R., et al. Mechanism of superoxide anion production by hepatic sinusoidal endothelial cells and Kupffer cells during short-term ethanol perfusion in the rat. Liver 22 (2002) 321-329
45. Gryglewski R.J., Palmer R.M., and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320 (1986) 454-456
46. Karaa A., Kamoun W.S., Xu H., Zhang J., and Clemens M.G. Differential effects of oxidative stress on hepatic endothelial and Kupffer cell eicosanoid release in response to endothelin-1. Microcirculation 13 (2006) 457-466
47. Jackson T.S., Xu A., Vita J.A., and Keaney Jr. J.F. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83 (1998) 916-922
48. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., and Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97 (1996) 22-28
49. Taddei S., Virdis A., Ghiadoni L., Magagna A., and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97 (1998) 2222-2229
50. Morales-ruiz M., Cejudo-martin P., Fernandez-varo G., Tugues S., Ros J., Angeli P., et al. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 125 (2003) 522-531
51. Liu S., Premont R.T., Kontos C.D., Zhu S., and Rockey D.C. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med 11 (2005) 952-958
52. Merkel S.M., Kamoun W., Karaa A., Korneszczuk K., Schrum L.W., and Clemens M.G. LPS inhibits endothelin-1-mediated eNOS translocation to the cell membrane in sinusoidal endothelial cells. Microcirculation 12 (2005) 433-442
53. Kamoun W.S., Karaa A., Kresge N., Merkel S.M., Korneszczuk K., and Clemens M.G. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1. Hepatology 43 (2006) 182-190
54. Thiele G.M., Duryee M.J., Freeman T.L., Sorrell M.F., Willis M.S., Tuma D.J., et al. Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol. Biochem Pharmacol 70 (2005) 1593-1600
55. Jarnagin W.R., Rockey D.C., Koteliansky V.E., Wang S.S., and Bissell D.M. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127 (1994) 2037-2048
56. Fulton D., Gratton J.P., and Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J Pharmacol Exp Ther 299 (2001) 818-824
57. Sessa W.C. eNOS at a glance. J Cell Sci 117 (2004) 2427-2429
58. Iwakiri Y., Tsai M.H., McCabe T.J., Gratton J.P., Fulton D., Groszmann R.J., et al. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. Am J Physiol Heart Circ Physiol 282 (2002) H2084-H2090
59. Abraldes J.G., Iwakiri Y., Loureiro-Silva M., Haq O., Sessa W.C., and Groszmann R.J. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 290 (2006) G980-G987
60. Fernandez M., Mejias M., Angermayr B., Garcia-Pagan J.C., Rodes J., and Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 43 (2005) 98-103
61. Rudge J.S., Thurston G., Davis S., Papadopoulos N., Gale N., Wiegand S.J., et al. VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets. Cold Spring Harb Symp Quant Biol 70 (2005) 411-418
62. Garcia-Cardena G., Oh P., Liu J., Schnitzer J.E., and Sessa W.C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93 (1996) 6448-6453
63. Liu J., Garcia-Cardena G., and Sessa W.C. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35 (1996) 13277-13281
64. Sowa G., Liu J., Papapetropoulos A., Rex-Haffner M., Hughes T.E., and Sessa W.C. Trafficking of endothelial nitric-oxide synthase in living cells. Quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion. J Biol Chem 274 (1999) 22524-22531
65. Iwakiri Y., Murata T., Gao H., Loureiro-Silva M., Sessa W.C., and Groszmann R.J. Altered intracellular eNOS localization leads to an excessive NO production in the splanchnic arterial circulaiton in cirrhotic rats with portal hypertension. Hepatology 44 (2006) 354A
66. Fulton D., Babbitt R., Zoellner S., Fontana J., Acevedo L., McCabe T.J., et al. Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release. J Biol Chem 279 (2004) 30349-30357
67. Chen Y.C., Gines P., Yang J., Summer S.N., Falk S., Russell N.S., et al. Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats. Hepatology 39 (2004) 1075-1087
68. Fernandez M., and Bonkovsky H.L. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 29 (1999) 1672-1679
69. Fernandez M., Lambrecht R.W., and Bonkovsky H.L. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. J Hepatol 34 (2001) 812-817
70. De las Heras D., Fernandez J., Gines P., Cardenas A., Ortega R., Navasa M., et al. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology 38 (2003) 452-459
71. Fernandez M., and Bonkovsky H.L. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br J Pharmacol 139 (2003) 634-640
72. Angermayr B., Mejias M., Gracia-Sancho J., Garcia-Pagan J.C., Bosch J., and Fernandez M. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. J Hepatol 44 (2006) 1033-1039
73. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37 (1997) 517-554
74. Naik J.S., and Walker B.R. Heme oxygenase-mediated vasodilation involves vascular smooth muscle cell hyperpolarization. Am J Physiol Heart Circ Physiol 285 (2003) H220-H228
75. Ishizaka N., and Griendling K.K. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension 29 (1997) 790-795
76. Zakhary R., Gaine S.P., Dinerman J.L., Ruat M., Flavahan N.A., and Snyder S.H. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA 93 (1996) 795-798
77. Cruse I., and Maines M.D. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J Biol Chem 263 (1988) 3348-3353
78. Claesson H.E., Lindgren J.A., and Hammarstrom S. Elevation of adenosine 3′,5′-monophosphate levels in 3T3 fibroblasts by arachidonic acid: evidence for mediation by prostaglandin I2. FEBS Lett 81 (1977) 415-418
79. Ohta M., Kishihara F., Hashizume M., Kawanaka H., Tomikawa M., Higashi H., et al. Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy. Prostaglandins Leukot Essent Fatty Acids 53 (1995) 41-45
80. Sitzmann J.V., Campbell K., Wu Y., and St Clair C. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension. Surgery 115 (1994) 290-294
81. Munoz J., Albillos A., Perez-Paramo M., Rossi I., and Alvarez-Mon M. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats. Am J Physiol 276 (1999) G687-G693
82. Wagner J.A., Varga K., Ellis E.F., Rzigalinski B.A., Martin B.R., and Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390 (1997) 518-521
83. Ros J., Claria J., To-Figueras J., Planaguma A., Cejudo-Martin P., Fernandez-Varo G., et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 122 (2002) 85-93
84. Batkai S., Jarai Z., Wagner J.A., Goparaju S.K., Varga K., Liu J., et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7 (2001) 827-832
85. Hosoki R., Matsuki N., and Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237 (1997) 527-531
86. Zhao W., and Wang R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283 (2002) H474-H480
87. Cheng Y., Ndisang J.F., Tang G., Cao K., and Wang R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287 (2004) H2316-H2323
88. Zhao W., Zhang J., Lu Y., and Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20 (2001) 6008-6016
89. Fiorucci S., Antonelli E., Mencarelli A., Orlandi S., Renga B., Rizzo G., et al. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42 (2005) 539-548
90. Keaney Jr. J.F., Simon D.I., Stamler J.S., Jaraki O., Scharfstein J., and Vita J.A. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 91 (1993) 1582-1589
91. Laleman W., Wilmer A., Evenepoel P., Elst I.V., Zeegers M., Zaman Z., et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10 (2006) R108
92. Schmidt L.E., Wang L.P., Hansen B.A., and Larsen F.S. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 9 (2003) 290-297